Private Equity
Location
Rotterdam, The Netherlands
Boston, MA, USA
Private Equity
All Portfolio items
See full Private Equity portfolio
Viroclinics Biosciences is a leader in diagnostic and clinical-trial services. It is one of the few labs in the world able to perform highly complex, specialized diagnostic and preclinical studies in the field of virology. Viroclinics operates globally as the preferred virology testing laboratory for top-ten biopharmaceutical companies.
Gilde acquired a majority share in 2013. During Gilde ownership Viroclinics developed new services for the biopharmaceutical industry, expanded its facilities and tripled its revenues. Viroclinics was sold in 2017 to Parcom Capital.
More Viroclinics Biosciences news
d3 Medicine LLC and Viroclinics Biosciences BV form virology drug development alliance to serve the
Gilde Healthcare Services acquires majority share in Viroclinics Biosciences from Erasmus MC
Private Equity
Symeres
Symeres, previously known as Mercachem and Syncom, is a leading mid-sized European contract research organization (CRO) for integrated outsourced drug discovery services. Symeres focuses on serving smaller and midsized players with the quality and professional standards of larger CROs, enabling
Private Equity
Eetgemak
Eetgemak is a leading producer and supplier of chilled meals, meal components, and dietary meals to the healthcare industry. The company supplies key institutions such as care homes, hospitals, schools and caterers, amongst others. Eetgemak delivers freshly prepared, healthier, and
Private Equity
Novicare
Novicare provides B2B outsourced specialist medical and paramedical (tele)care services for elderly patients and people with disabilities in the Netherlands. It treats patients with complex and chronic conditions in both care institutions and domiciliary settings. The company’s multidisciplinary team comprises
